A Comprehensive Study to Isolate Tumor-initiating Cells From Human Epithelial Malignancies

Stanford University logo

Stanford University

Status

Withdrawn

Conditions

Bladder (Urothelial, Transitional Cell) Cancer Resectable (Pre-Cystectomy)
Bladder Cancer
Skin Cancers
Bladder (Urothelial, Transitional Cell) Cancer

Study type

Observational

Funder types

Other
NIH

Identifiers

NCT01060319
SU-11062009-4360 (Other Identifier)
BLDR0011

Details and patient eligibility

About

We hypothesize that all human malignancies harbour a subpopulation of tumor initiating cells/cancer stem cells (CSCs) that drives tumor development and potentially recurrence or metastasis of the disease. The primary aim of this study is to develop strategies for prospective isolation/enrichment of CSCs from human tumors of different tissue origins. In addition, we will characterize the signaling pathways and/or tumor specific antigens that are specific for CSCs, in order to specifically target these CSCs as the endpoint of this study.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:N/A. We will recruit all non-melanoma skin and bladder cancer patients that are recommended for surgical removal of tumor tissues. This includes patients from all ages, gender and ethnicity background. Our sample collection criteria based on the tumor size of individual (e.g. tumor samples will only be collected if it will not affect the pathological diagnosis or treatment procedures of patients). Exclusion Criteria:N/A

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems